Added to YB: 2025-05-14
Pitch date: 2025-05-09
STVN [neutral]
Stevanato Group S.p.A.
-11.52%
current return
Author Info
Best Anchor Stocks shares deep research on companies with long-term potential aThe Bear Cavend lower-than-average volatility. Sign up for the newsletter.
Company Info
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Market Cap
$5.2B
Pitch Price
$24.07
Price Target
N/A
Dividend
0.28%
EV/EBITDA
20.28
P/E
37.31
EV/Sales
4.72
Sector
Life Sciences Tools and Services
Category
growth
Sandbagging…anyone? - Stevanato Group S.p.A.
STVN (earnings update): Q1 revenue +9% (8% CC), net income +41% beating estimates. Margin expansion amid headwinds: Engineering still underperforming, Latina/Fishers ramping, vial underutilization. HVP shift (50% of BDS) offers 900bps margin upside. Management sandbagging 2025 guidance (6.4% growth) despite Q1 momentum; 10.5% growth achievable.
Read full article (6 min)